CATX Perspective Therapeutics
- 3.4700
- +0.4700+15.67%
- 3.5100
- +0.0400+1.15%
Perspective Therapeutics News
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avidity Partners Management LP(5.3%),Avidity Partners Management (GP) LLC(5.3%), etc.
Perspective Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(4.96%),Commodore Capital Master LP(4.96%)
Perspective Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(7.1%)
Perspective Therapeutics | 10-Q: Q3 2024 Earnings Report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)
Perspective Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.083%),Abigail P. Johnson(14.083%)
Perspective Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(8.164%),Abigail P. Johnson(8.164%)
Perspective Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 424B5: Prospectus
Analysis
Price Target
No Data
No Data